glp-1 gastric intestinal obstruction lawsuit in michigan Ozempic – July 2026 Update Michigan obesity trends GLP-1
Description
GLP-1 RAs reduce cardiovascular risks but may cause nausea and GI issues
One cross-sectional study from 2017 surveyed patients and physicians in the USA, Italy, France, Germany, Spain, and the UK on problems experienced with GLP-1RA
The timeline can vary wildly
The concern about these medications and cancer stems from several factors
Fatty infiltration of the pancreas promotes impaired pancreatic -cell function and gradual hyperglycemia, which will further enhance de novo hepatic lipogenesis and promote higher NEFAs levels to the circulation (the twin cycle hypothesis) [18]
This also means that the pylorus, which controls the movement of food to the small intestine is bypassed
